China, New Products

Bristol-Myers wins the frenzied race to a first approval for a PD-1/L1 checkpoint in China as regulators hustle up a quick OK

Results

In the glare of an intense gene therapy spotlight, bluebird continues to tout each small step forward for its pioneering LentiGlobin

IPOs

Verrica Pharma bankrolls PhIII with a $75M IPO raise for lead skin drug
More news caret

calendar Protocols

Quick hits from around the biopharma web

Jun 14

Sanofi sells manufacturing site to Recipharm; Aptose buys rights to sell CrystalGenomics' cancer drug in China

Jun 13

BridgeBio doubles down on rare disease with CoA launch; Beleaguered scPharmaceuticals' shares wilt again on FDA's rejection letter

Jun 12

Idera shares slide on PhII failure; WuXi blueprints $60M manufacturing center in Worcester, MA

Jun 11

BridgeBio bags Alexion's ultra-rare disease asset; Allergan touts a new set of late-stage data for oral CGRP drug

More Protocols caret

Dollar Premium

The 2-trial hurdle for drug approvals is steadily losing ground. Are we devaluing the industry's R&D gold standard?

Where does the science come from? The top 20 NIH-funded institutions in 2017

The good, the bad and the ugly for the top 15 spenders in the global drug R&D business: 2018

Bristol-Myers offers some eagerly awaited Checkmate-227 results, but they're not changing medical practice -- yet

What are the top 10 corporate VCs in biopharma today? And what do they want to fund — or steer clear of?

Where the money is: Top 100 VCs investing in US biotechs during 2017

twitter Marco

Hot BioTwitter bot - last updated ago

arrow-thick Most Viral

U.S. Files Criminal Charges Against Theranos's Elizabeth Holmes, Ramesh Balwani

WSJ a day

New Bluebird data show promising benefits for gene therapy, if they last

STAT a day

Controversial NIH study of 'moderate drinking' will be terminated

STAT a day

Theranos founder Elizabeth Holmes out as CEO, three months after 'massive fraud' claims

CNBC Dan Mangan a day

Theranos founder Elizabeth Holmes indicted for alleged fraud; out as CEO

STAT a day

Life sciences companies could see changes in collaborations with new accounting standard - Boston Business Journal

Boston Business Journal Jeff Ellis and Dennis Howell a day

Bluebird Bio Gene Therapies Show Promise Against Deadly Anemias

Forbes a day

GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress

Yahoo a day

Xconomy: For Sickle Cell, a Complex Disease, New Drugs Could Bring Complex Costs

Xconomy Alex Lash a day

Exosomes Shown to Be Involved in Spread of Amyloid Beta in Alzheimer's | GEN

GEN a day

timer Latest

GEN

Exosomes Shown to Be Involved in Spread of Amyloid Beta in Alzheimer's | GEN

Bloomberg

Lab-Grown Meat Startups Backed by Bill Gates, Tyson Foods Face FDA Oversight

The Niche

Stem-ish cells: what's the real thing? - The Niche

OncLive

Dr. Mato Discusses the Safety and Efficacy of Umbralisib in CLL

Modern Healthcare

Gottlieb sets a new standard for FDA commissioner

MobiHealthNews

In-Depth: Consumer genomics furthers healthcare foothold but privacy, resource concerns persist

JAMA

Bone Complications in Patients With Cancer

Sciencedaily

Study found people would rather pop a pill or sip tea than exercise to treat high blood pressure

New Scientist

Wake-up call: How a lack of sleep can cause Alzheimer's

Boston Business Journal

Life sciences companies could see changes in collaborations with new accounting standard - Boston Business Journal

fire Hot This Week

1

STAT

CRISPR-edited cells might cause cancer, finds two studies

2

WSJ

U.S. Files Criminal Charges Against Theranos's Elizabeth Holmes, Ramesh Balwani

3

STAT

New Bluebird data show promising benefits for gene therapy, if they last

4

STAT

Controversial NIH study of 'moderate drinking' will be terminated

5

Forbes

A Story Of Devastation And Rebirth -- The Former Pfizer Research Labs In Ann Arbor

6

WSJ

Ever Heard of Iqvia? Its CEO Made $38 Million

7

BioCentury

BIO chair outraged by nude dancer party

8

Bloomberg

Drugmaker Revives Female Libido Pill at Half the Price

9

CNBC

Theranos founder Elizabeth Holmes out as CEO, three months after 'massive fraud' claims

10

ENDPOINTS NEWS

Sanofi builds on mRNA alliances with an $805M pact for Ron Renaud's Translate Bio

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
← Go back